Back
EHRA Premium Access

Usefulness of left ventricular end-systolic elastance calculated non-invasively for predictor of tachycardia-induced cardiomyopathy at heart failure-reduced ejection fraction

Session: Poster session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome
Topic: Heart Failure in Atrial Fibrillation
Speaker: Doctor M. Takahashi (Tokyo, JP)
Event: EHRA 2019

Congress Presentation

About the speaker

Doctor Masao Takahashi

Tokyo Metropolitan Hiroo Hospital, Tokyo (Japan)
0 follower

8 more presentations in this session

The association between insulin resistance and incidence of atrial fibrillation in non-diabetics: findings from Ansung-Ansan cohort of the national genome and epidemiology study

Speaker: Associate Professor J. Park (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Difference of symptom characteristics of atrial fibrillation in patients with concomitant left ventricular dysfunction

Speaker: Associate Professor J. Park (Seoul, KR)

Access
Abstract
Slides
Thumbnail

Left atrial size and function in atrial fibrillation progression

Speaker: Associate Professor T. Seewoester (Leipzig, DE)

Access
Abstract
Thumbnail

Do DDD pacemakers increase the incidence of atrial fibrillation?

Speaker: Doctor P. Amador (Setubal, PT)

Access
Abstract
Slides
Thumbnail

Long term impact of metabolic syndrome management on mortality in patients with atrial fibrillation

Speaker: Associate Professor Y. Baek (Incheon, KR)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

Speakers: Doctor M. Takahashi, Associate Professor J. Park, Associate Professor J. Park, Associate Professor T. Seewoester, Doctor P. Amador...
Access
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb